Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter
213Bi radionuclide
cancer cells
cubosomes
cytotoxicity
doxorubicin
α-therapy
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
pubmed:
19
7
2022
medline:
3
8
2022
entrez:
18
7
2022
Statut:
ppublish
Résumé
Here, we propose tailored lipid liquid-crystalline carriers (cubosomes), which incorporate an anticancer drug (doxorubicin) and complexed short-lived α-emitter (bismuth-213), as a strategy to obtain more effective action toward the cancer cells. Cubosomes were formulated with doxorubicin (DOX) and an amphiphilic ligand (DOTAGA-OA), which forms stable complexes with
Identifiants
pubmed: 35849547
doi: 10.1021/acs.molpharmaceut.2c00182
pmc: PMC9346610
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
Ligands
0
Lipids
0
Doxorubicin
80168379AG
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2818-2831Références
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2106-19
pubmed: 25070685
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):614-622
pubmed: 30498897
Eur J Pharm Biopharm. 2016 Jul;104:148-55
pubmed: 27163239
Radiother Oncol. 2004 Dec;73 Suppl 2:S119-22
pubmed: 15971325
J Colloid Interface Sci. 2020 Aug 1;573:176-192
pubmed: 32278949
Langmuir. 2014 Feb 11;30(5):1383-90
pubmed: 24443890
Nanomaterials (Basel). 2019 Apr 19;9(4):
pubmed: 31010165
J Nucl Med. 2018 May;59(5):795-802
pubmed: 29326358
PLoS One. 2014 Feb 07;9(2):e88239
pubmed: 24516620
Cell Death Dis. 2020 Jan 2;11(1):1
pubmed: 31911576
Cardiovasc Drugs Ther. 2017 Feb;31(1):63-75
pubmed: 28185035
Langmuir. 2019 Nov 12;35(45):14532-14542
pubmed: 31635451
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1636-1644
pubmed: 29713762
Chempluschem. 2021 May 11;86(7):982-990
pubmed: 33977667
Phys Chem Chem Phys. 2011 Feb 28;13(8):3004-21
pubmed: 21183976
Signal Transduct Target Ther. 2018 Mar 16;3:7
pubmed: 29560283
Langmuir. 2015 Nov 24;31(46):12753-61
pubmed: 26513537
Int J Pharm. 2009 Jan 5;365(1-2):190-9
pubmed: 18790030
Curr Radiopharm. 2018;11(3):200-208
pubmed: 29732998
Biomaterials. 2000 Feb;21(3):223-34
pubmed: 10646938
Chempluschem. 2017 Apr;82(4):570-575
pubmed: 31961592
Pharmacology. 2009;84(5):300-9
pubmed: 19829019
Bioconjug Chem. 2008 Jun;19(6):1274-82
pubmed: 18505278
Int J Mol Sci. 2020 Jul 17;21(14):
pubmed: 32708846
Chem Soc Rev. 2012 Feb 7;41(3):1297-322
pubmed: 21975366
Nanomaterials (Basel). 2020 Jul 13;10(7):
pubmed: 32668687
Langmuir. 2015 Nov 24;31(46):12770-6
pubmed: 26513646
Curr Pharm Des. 2013;19(18):3329-41
pubmed: 23431995
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1886-97
pubmed: 22872310
Anticancer Res. 2006 Jul-Aug;26(4B):2841-8
pubmed: 16886603
Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1788-97
pubmed: 21553086
Nucl Med Biol. 2007 Oct;34(7):779-85
pubmed: 17921029
Mol Pharm. 2020 Sep 8;17(9):3553-3566
pubmed: 32787284
Ther Deliv. 2015;6(12):1347-64
pubmed: 26652281
Mol Imaging Biol. 2010 Apr;12(2):198-203
pubmed: 19543946
Clin Cancer Res. 2010 Nov 1;16(21):5303-11
pubmed: 20858843
Cancer Biol Ther. 2005 Dec;4(12):1318-24
pubmed: 16322682
Bioelectrochemistry. 2006 Sep;69(1):82-7
pubmed: 16443398
Drug Discov Today. 2010 Dec;15(23-24):1032-40
pubmed: 20934534
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138
pubmed: 30232539
Angew Chem Int Ed Engl. 2019 Mar 4;58(10):2958-2978
pubmed: 29926520
Bioconjug Chem. 2007 Nov-Dec;18(6):2061-7
pubmed: 17935286
Nanomaterials (Basel). 2020 Nov 16;10(11):
pubmed: 33207760
Drug Discov Today. 2016 May;21(5):789-801
pubmed: 26780385
Appl Radiat Isot. 2013 Apr;74:123-7
pubmed: 23416406
Biomaterials. 2017 Jun;130:67-75
pubmed: 28365545
Nanomaterials (Basel). 2020 May 18;10(5):
pubmed: 32443582
Cancer Res. 2010 Sep 1;70(17):6815-23
pubmed: 20651254
Nat Commun. 2015 Nov 17;6:8915
pubmed: 26573367
Blood. 2002 Aug 15;100(4):1233-9
pubmed: 12149203
Adv Colloid Interface Sci. 2017 Nov;249:331-345
pubmed: 28477868
Eur J Pharmacol. 2009 Dec 25;625(1-3):55-62
pubmed: 19836381
Cancer. 2012 Apr 15;118(8 Suppl):2270-6
pubmed: 22488701
J Nucl Med. 2004 Feb;45(2):253-60
pubmed: 14960644
Curr Radiopharm. 2012 Jul;5(3):221-7
pubmed: 22642390
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1364-1371
pubmed: 29644393
Nucl Med Biol. 2004 May;31(4):441-9
pubmed: 15093814
Immunotherapy. 2011 Sep;3(9):1041-50
pubmed: 21913827
Cancer Biol Ther. 2007 Jun;6(6):846-52
pubmed: 17495524
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567